Phytochemicals impact on osteogenic differentiation of mesenchymal stem cells
- 9 October 2020
- journal article
- review article
- Published by Wiley in BioFactors
- Vol. 46 (6) , 874-893
Abstract
Medicinal plants have always been utilized for the prevention and treatment of the spread of different diseases all around the world. To name some traditional medicine that has been used over centuries, we can refer to phytochemicals such as naringin, icariin, genistein, and resveratrol gained from plants. Osteogenic differentiation and mineralization of stem cells can be the result of specific bioactive compounds from plants. One of the most appealing choices for therapy can be mesenchymal stem cells (MSCs) because it has a great capability of self‐renewal and differentiation into three descendants, namely, endoderm, mesoderm, and ectoderm. Stem cell gives us the glad tidings of great advances in tissue regeneration and transplantation field for treatment of diseases. Using plant bioactive phytochemicals also holds tremendous promises in treating diseases such as osteoporosis. The purpose of the present review article thus is to investigate what are the roles and consequences of phytochemicals on osteogenic differentiation of MSCs.Keywords
This publication has 157 references indexed in Scilit:
- A Novel Semisynthetic Molecule Icaritin Stimulates Osteogenic Differentiation and Inhibits Adipogenesis of Mesenchymal Stem CellsInternational Journal of Medical Sciences, 2013
- Resveratrol Exerts Dosage and Duration Dependent Effect on Human Mesenchymal Stem Cell DevelopmentPLOS ONE, 2012
- Psoralen stimulates osteoblast differentiation through activation of BMP signalingBiochemical and Biophysical Research Communications, 2011
- Human Bone Marrow Mesenchymal Stem Cells: A Systematic Reappraisal Via the Genostem ExperienceStem Cell Reviews and Reports, 2010
- Petroleum Ether Extract of Cissus Quadrangularis (Linn.) Enhances Bone Marrow Mesenchymal Stem Cell Proliferation and Facilitates OsteoblastogenesisClinics, 2009
- Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative MedicineJournal of Dental Research, 2009
- Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose TissueStem Cells, 2006
- Mesenchymal Stem Cells Derived from CD133‐Positive Cells in Mobilized Peripheral Blood and Cord Blood: Proliferation, Oct4 Expression, and PlasticityStem Cells, 2005
- Osteoclast differentiation and activationNature, 2003
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001